The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,387.00
Bid: 2,387.00
Ask: 2,388.00
Change: 32.00 (1.36%)
Spread: 1.00 (0.042%)
Open: 2,366.00
High: 2,402.00
Low: 2,363.00
Prev. Close: 2,355.00
BATS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Final Terms

25 Jun 2020 15:34

RNS Number : 1266R
British American Tobacco PLC
25 June 2020
 

Publication of Final Terms

The following final terms (the "Final Terms") are available for viewing:

Final Terms for B.A.T. International Finance p.l.c.'s £500,000,000 2.250 per cent. Guaranteed Notes due 2028 (the "Notes") issued pursuant to the base prospectus dated 31 March 2020 (as supplemented by the supplemental prospectus dated 18 June 2020) (together, the "Prospectus") in connection with the £25,000,000,000 Euro Medium Term Note Programme of B.A.T. International Finance p.l.c., B.A.T Capital Corporation and B.A.T. Netherlands Finance B.V. (as Issuers) and British American Tobacco p.l.c. and each of the Issuers (except where it is the relevant Issuer) (as Guarantors).

The Final Terms for the Notes contain the final terms of the Notes. The Final Terms of the Notes must be read in conjunction with the Prospectus, which constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129.

To view the full document, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/1266R_1-2020-6-25.pdf

The Final Terms have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Enquiries

British American Tobacco Press Office+44 (0)20 7845 2888 (24 hours) │@BATPress

Investor RelationsMike Nightingale / Victoria Buxton / William Houston / John Harney:

+44 (0)20 7845 1180/2012/1138/1263

British American Tobacco p.l.c.Globe House4 Temple PlaceLondon WC2R 2PG

25 June 2020

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Final Terms (when read together with the Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms or the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

The Notes have not been registered under the Securities Act or any relevant securities laws of any state of the United States, and may not be offered or sold in the United States absent registration or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFTZELFLBQLLBBX
Date   Source Headline
31st May 202310:45 amRNSDirector/PDMR Shareholding
24th May 20234:35 pmRNSDirector/PDMR Shareholding
22nd May 20232:00 pmRNSHolding(s) in Company
15th May 20237:00 amRNSBAT announces Tadeu Marroco as Chief Executive
12th May 20234:45 pmRNSDirector/PDMR Shareholding
12th May 202312:10 pmRNSHolding(s) in Company
11th May 20233:25 pmRNSDirector/PDMR Shareholding
9th May 20234:00 pmRNSDirector/PDMR Shareholding
5th May 20232:55 pmRNSDirector/PDMR Shareholding
5th May 20232:50 pmRNSDirector/PDMR Shareholding
5th May 20232:45 pmRNSDirector/PDMR Shareholding
4th May 20233:35 pmRNSDirector/PDMR Shareholding
4th May 20231:10 pmRNSDirector/PDMR Shareholding
2nd May 20239:50 amRNSTotal Voting Rights
25th Apr 20234:05 pmRNSAgreement with the US Department of Justice
24th Apr 20237:15 amRNSDirector Declaration
19th Apr 20235:45 pmRNSResult of AGM
19th Apr 202311:45 amRNSAGM Statement
6th Apr 20231:20 pmRNSDirector/PDMR Shareholding
5th Apr 20234:15 pmRNSDirector/PDMR Shareholding
3rd Apr 20234:39 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:05 amRNSTotal Voting Rights
31st Mar 20234:55 pmRNSDirector/PDMR Shareholding
31st Mar 20234:50 pmRNSDirector/PDMR Shareholding
31st Mar 20234:45 pmRNSDirector/PDMR Shareholding
23rd Mar 20232:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20232:45 pmRNSDirector/PDMR Shareholding
23rd Mar 20232:40 pmRNSDirector/PDMR Shareholding
14th Mar 20234:47 pmRNSPublication of a Prospectus
14th Mar 20238:00 amRNSNotice of AGM
13th Mar 20233:10 pmRNSDirector/PDMR Shareholding
13th Mar 20237:00 amRNSBranch Register: Dividend Finalisation Information
9th Mar 202310:35 amRNSDirector/PDMR Shareholding
8th Mar 202311:10 amRNSDirector/PDMR Shareholding
3rd Mar 20234:40 pmRNSDirector/PDMR Shareholding
3rd Mar 202310:15 amRNSDirector Declaration
2nd Mar 20234:55 pmRNSAnnual Financial Report
1st Mar 202310:00 amRNSTotal Voting Rights
23rd Feb 202311:15 amRNSDirector/PDMR Shareholding
15th Feb 20236:05 pmRNSDirector Declaration
15th Feb 202310:30 amRNSDirector/PDMR Shareholding
14th Feb 20236:15 pmRNSPublication of Final Terms
13th Feb 202310:00 amRNSDirector/PDMR Shareholding
9th Feb 20234:10 pmRNSPublication of Supplementary Prospectus
9th Feb 20237:03 amRNSFinal Results
6th Feb 202312:35 pmRNSDirector/PDMR Shareholding
6th Feb 202312:30 pmRNSDirector/PDMR Shareholding
6th Feb 202312:25 pmRNSDirector/PDMR Shareholding
6th Feb 202312:20 pmRNSDirector/PDMR Shareholding
6th Feb 202312:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.